Influence of specific comorbidities on survival after early-stage breast cancer

References

• Land LH, Dalton SO, Jørgensen TL, et al. Comorbidity and survival after early breast cancer. A review. Crit Rev Oncol/Hematol. 2012;81:196–205.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–383.
   PubMedGoogle Scholar
• Hong CC, Ambrosone CB, Goodwin PJ. Comorbidities and their management: potential impact on breast cancer outcomes. Adv Exp Med Biol. 2015;862:155–175.
   PubMed Web of Science ®Google Scholar
• Land LH, Dalton SO, Jensen M-B, et al. Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer. Br J Cancer. 2012;107:1901–1907.
   PubMed Web of Science ®Google Scholar
• Wollschläger D, Meng X, Wöckel A, et al. Comorbidity-dependent adherence to guidelines and survival in breast cancer—is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J. 2017 [cited 2017 Jul 7]. DOI:10.1111/tbj.12855. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Patnaik JL, Byers T, DiGuiseppi C, et al. The influence of comorbidities on overall survival among older women diagnosed with breast cancer. J Natl Cancer Inst. 2011;103:1101–1111.
   PubMedGoogle Scholar
• Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol. 2011;29:40–46.
   PubMed Web of Science ®Google Scholar
• Ranc K, Jørgensen ME, Friis S, et al. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment. Diabetologia. 2014;57:927–934.
   PubMed Web of Science ®Google Scholar
• Christensen P, Ejlertsen B, Jensen M-B, et al. Danish Breast Cancer Cooperative Group. Clin Epidemiol. 2016;8:445–449.
   PubMed Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39:30–33.
   PubMed Web of Science ®Google Scholar
• Helweg-Larsen K. The Danish register of causes of death. Scand J Public Health. 2011;39:26–29.
   PubMed Web of Science ®Google Scholar
• Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17:343–346.
   PubMedGoogle Scholar
• Edwards BK, Noone A-M, Mariotto AB, et al. Annual Report to the Nation on the Status of Cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast or prostate cancer. Cancer. 2014;120:1290–1314.
   PubMed Web of Science ®Google Scholar
• Ording AG, Cronin-Fenton DP, Jacobsen JB, et al. Comorbidity and survival of Danish breast cancer patients from 2000 to 2011: a population-based cohort study. Clin Epidemiol. 2013;5:39–46.
   PubMedGoogle Scholar
• Goodwin PJ, Ennis M, Pritchard KI, et al. Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J Clin Oncol. 2011;30:164–171.
   PubMed Web of Science ®Google Scholar
• Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–998.
   PubMed Web of Science ®Google Scholar
• McGale P, Darby SC, Hall P, et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol. 2011;100:167–175.
   PubMed Web of Science ®Google Scholar
• Sawyer DB. Anthracyclines and heart failure. N Engl J Med. 2013;368:1154–1156.
   PubMed Web of Science ®Google Scholar
• Rehammar JC, Jensen M-B, McGale P, et al. Risk of heart disease in relation to radiotherapy and chemotherapy with anthracyclines among 19,464 breast cancer patients in Denmark, 1977–2005. Radiother Oncol. 2017;123:299–305.
   PubMed Web of Science ®Google Scholar
• Carstensen B, Borch-Johnsen K. Register-based studies of diabetes. Scand J Public Health. 2011;39:175–179.
   PubMed Web of Science ®Google Scholar
• Forbes JM, Fotheringham AK. Vascular complications in diabetes: old messages, new thoughts. Diabetologia. 2017;60:2129–2138.
   PubMed Web of Science ®Google Scholar